ReviewAbdominal radiology (New York)2026
CT presentations of pancreatic lymphoma: what radiologists need to know.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic lymphoma is a rare entity that can mimic other pancreatic pathologies, particularly pancreatic ductal adenocarcinoma (PDAC), making accurate radiologic recognition essential as management differs significantly. Pancreatic lymphoma is treated with chemotherapy and generally carries a more favorable prognosis, whereas PDAC typically requires surgical intervention. Through a series of illustrative cases, many of which were initially referred to a PDAC multidisciplinary conference but ultimately proven to be lymphoma, we highlight the diverse CT imaging spectrum of pancreatic lymphoma, which extends well beyond the classically described bulky pancreatic mass. Observed patterns include focal well-defined hypodense masses, multifocal pancreatic lesions, diffuse infiltrative enlargement mimicking pancreatitis, and masses with extrapancreatic spread into adjacent organs. While classic features such as absent pancreatic ductal dilatation, lack of vascular occlusion, and homogeneous hypoattenuation can help distinguish lymphoma from PDAC, variant presentations with ductal dilation, necrosis, or vascular involvement may occur. Awareness of these diverse imaging appearances may help radiologists include pancreatic lymphoma in the differential diagnosis of hypodense pancreatic masses, advising tissue sampling to ensure accurate diagnosis and guide appropriate management.
Indexed as
Identifiers
42118274What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.